Market closed · After hours · 6:32 PM ET
Last update: Oct 29, 2026, 6:16 PM ET
Penumbra, Inc.
$321.97▲ 1.15% today
After Hours

Why Penumbra, Inc. (PEN) stock moved

Updated Oct 29, 2026

Penumbra, Inc. (PEN) shares rose 1.1% to $321.97 as of October 29, 2026, a modest gain from the prior close of $318.31. BestStocks flagged the session as a major change for PEN. The move is tied to company news. Below, we break down what changed for PEN, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

Company News

Penumbra reported Q3 2026 financial results with revenue and profitability metrics for the quarter ended September 30. Q3 results reveal company's thrombectomy market performance and trajectory toward full-year 2026 guidance.

This summary describes the catalyst and move as first detected on Oct 29, 2026, 4:51 PM EDT; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
NewsLow confidence
Rel. volume
1.9×
Above Avg
Vs peers
—
No comparable peers
Market cap
$12.7B
New York Stock Exchange
Analyst target
$320
-0.6% vs price
Price chart
Oct 29
Not enough price data.
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Penumbra, Inc. investors

For Penumbra, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Material positive event; Positive 1.1% session move. Weighing against that: New SEC filing — review for material disclosures; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $320.00, implying -0.6% downside from $321.97. BestStocks rates the overall signal quality low (47/100). With earnings roughly 6 days out, the next report is the most likely near-term test of the move.

PEN price reaction

PEN last traded at $321.97, up $3.66 (+1.15%) from the previous close of $318.31. The session traded on 1.9× average volume (above avg), so the move carried above-average conviction.

Bullish and bearish analyst opinions on Penumbra, Inc. (PEN)

Latest catalyststrengthens the bull case
The latest catalyst — positive company news — it strengthens the bull case.

The consensus analyst price target on Penumbra, Inc. (PEN) is $320.00, 0.6% below the recent $321.97. Here is how the bullish and bearish cases on PEN line up.

The bullish case

  • Material positive event.
  • Positive 1.1% session move.
  • Positive price momentum.

The bearish case

  • The consensus analyst price target of $320.00 sits 0.6% below the recent $321.97, so the average target sees limited room to run.
  • The most bearish analyst target is $320.00 (-0.6%).
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Oct 29, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $320-0.6%
Evercore ISI Group maintained Outperform · 2026-07-06
SEC filings watch
No recent filings
Peer context
PEN+1.1%

Previous notable changes for PEN

Filings2026-10-29
Penumbra, Inc. (PEN) filed an 8-K on October 29, 2026. The filing did not disclose a specific triggering event in available records.
Valuation2026-10-28via uk.investing.com ↗
Penumbra is down 1.70% to $318.53 despite the web catalyst showing the stock slightly positive overall on Oct 28, 2026, following Boston Scientific's $14.5 billion acquisition announcement (uk.investing.com, finance.yahoo.com). The intraday decline may reflect profit-taking after the stock surged to an all-time high on the deal news; volume is elevated at 3.61x expected levels for this time of session, suggesting active repositioning.
Material / Earnings2026-10-26
Penumbra, Inc. (PEN) moved +0.27% from $324.33 to $325.22 on 2026-10-26. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move appears to be technical, with PEN reaching a new 30-day high on volume near its 5-day average.
Material / Earnings2026-10-22
Penumbra, Inc. (PEN) moved +0.39% to $324.96 on 2026-10-22 after the company's CAVT technology received FDA clearance for first-line deep vein thrombosis (DVT) treatment based on BOLT-DVT trial data.
Upcoming catalysts & outlook
Next earnings
2026-11-04 (est.)
in 6 days
Thesis shift
Neutral / Mixed
bullish signal
Risk level
Low
from change events

Frequently asked questions about PEN

Why did Penumbra, Inc. (PEN) stock move?

PEN rose 1.1% to $321.97. The move is associated with company news.

How much did PEN stock rise?

PEN gained 1.15% ($3.66) versus the prior close of $318.31, last trading at $321.97 on 1.9× average volume.

When is Penumbra, Inc.'s next earnings date?

PEN's next earnings report is estimated for 2026-11-04 — about 6 days away.

What is the analyst price target for PEN?

The consensus analyst price target for PEN is $320.00, about 0.6% below the current $321.97. Over the past 90 days, analysts recorded 0 upgrades, 0 maintains, and 0 downgrades.

How BestStocks tracks PEN

This page is generated automatically by BestStocks' change-detection system after company news was detected and verified against independent data sources. It draws on 20 tracked change events for PEN, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 29, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataCompany news feedsSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.